Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Themis Medicare Ltd. M&A Activity 2024

Nov 18, 2024

59390_rns_2024-11-18_5478e023-c0fe-4162-9550-1830704aa0e9.pdf

M&A Activity

Open in viewer

Opens in your device viewer

==> picture [102 x 48] intentionally omitted <==

Date: 18[th] November, 2024

To, BSE Limited National Stock Exchange of India Limited Sir Phiroze Jeejeebhoy Towers Exchange Plaza, 5[th] Floor Dalal Street, Fort Plot No. C-1, Block G Mumbai – 400001 Bandra Kurla Complex, Bandra (East) Security code: 530199 Mumbai – 400051 Scrip code: INE083B01024

Dear Sir/ Madam,

Sub: Submission of Press Release

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith a copy of the press release titled “ Amalgamation of Gujarat Themis Biosyn Limited with Themis Medicare Limited issued by the Company”.

The press release is also being disseminated on the Company’s website at www.themismedicare.com

We request you to kindly take the above on record.

Thanking you,

Yours faithfully,

For and on behalf of Themis Medicare Limited

Pradeep Digitally signed by Pradeep Manjunath Manjunath Chandan Date: 2024.11.18 20:53:09 Chandan +05'30'

Pradeep Chandan Director-legal, Compliance & Company Secretary

Themis Medicare Limited

Corporate Office: 11/12 Udyog Nagar, S V Road, Goregaon (W), Mumbai – 400 104, India Tel.:* 91-22-67607080 Fax: 91-22-67607070/ 28746621 Regd. Office: Plot No. 69-A, G.I.D.C., Industrial Estate, Vapi-Gujarat CIN No.: L24110GJ1969PLC001590 Tel/ Fax No.: Regd. Off.: 0260-2431447/ 2430219 E-mail:* [email protected] Website:* www.themismedicare.com

==> picture [102 x 48] intentionally omitted <==

Press Release

Amalgamation of Gujarat Themis Biosyn Limited with Themis Medicare Limited

Mumbai, 18[th] November, 2024

The Board of Directors of Gujarat Themis Biosyn Limited (GTBL) and Themis Medicare Limited (TML) have approved a Scheme of Amalgamation of Gujarat Themis Biosyn Limited with Themis Medicare Limited. The Scheme is subject to approval of the secured creditors and shareholders of TML and GTBL, the Stock Exchanges, SEBI, NCLT and other regulatory approvals as may be required.

This amalgamation will result in consolidation of businesses and integration of the entire product value chain under a single amalgamated entity, leading to significant synergies.

As per the joint equity share exchange ratio report issued by registered valuers, SSPA & Co., Chartered Accountants and GT Valuation Advisors Private Limited and as confirmed by the fairness opinions obtained from merchant banker Kunvarji Finstock Pvt. Ltd., TML will issue and allot 118 equity shares of the face value of Re. 1 each, credited as fully paid-up, for every 100 equity shares of the face value of Re. 1 each fully paid-up, held by shareholders in GTBL.

Khaitan & Co. acted as legal and tax advisors to the transaction.

Disclaimer: Certain statements in this “Press Release” may not be based on historical information or facts and may be “forward looking statements” within the meaning of applicable securities laws and regulations, including, but not limited to, those relating to general business plans & strategy of the Company, its future outlook & growth prospects, future developments in its businesses, its competitive & regulatory environment and management's current views & assumptions which may not remain constant due to risks and uncertainties. Actual results could differ materially from those expressed or implied. The Company assumes no responsibility to publicly amend, modify or revise any statement, on the basis of any subsequent development, information or events, or otherwise. This “Press Release” does not constitute a prospectus, offering circular or offering memorandum or an offer to acquire any shares and should not be considered as a recommendation that any investor should subscribe for or purchase any of the Company’s shares.

Themis Medicare Limited

Corporate Office: 11/12 Udyog Nagar, S V Road, Goregaon (W), Mumbai – 400 104, India Tel.:* 91-22-67607080 Fax:* 91-22-67607070/ 28746621

Regd. Office: Plot No. 69-A, G.I.D.C., Industrial Estate, Vapi-Gujarat CIN No.: L24110GJ1969PLC001590 Tel/ Fax No.: Regd. Off.:* 0260-2431447/ 2430219 E-mail: [email protected] Website: www.themismedicare.com